Flying L Partners
Private equityLate Stage · 5 people tracked
Find your way into Flying L Partners
8 people in our graph share verified history with the Flying L Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Flying L Partners is a partnership of experienced colleagues focused on driving innovation in the ophthalmic sector and generating value for investors. Its strategy is opportunity-driven: the firm first identifies a promising company, then raises capital specifically to invest in that opportunity, rather than deploying from a pre-committed blind pool. After investing, the partners engage deeply with the company to accelerate its progress, keeping a tight focus on innovation in eye care and related technologies.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from the firm's websiteWhat they invest in
from 8 of 10 portfolio companiesHealthtech ×6Biotech ×5Medical Devices ×4
HQs:United States×6
Investments · 10 tracked
founders shown can be your intro pathRxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed.
HealthtechMedical DevicesPasadena, US
Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)inRon Kurtz(President, Chief Executive Officer & Director)Mark Wilterding(Chief Financial Officer)in
Co-investorsForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersLongitude CapitalRA CapitalVisionary Ventures+2 more
Tarsus is a biopharmaceutical company focused on developing and delivering medicines that target the root cause of serious diseases with high unmet need, including eye conditions.
BiotechHealthtechMedical Devices
Bobak Azamian, MD, PhD(Founder)inBobak Azamian(President and Chief Executive Officer)inJeffrey Farrow(Chief Financial Officer and Chief Strategy Officer)Seshadri Neervannan(Chief Operating Officer)Aziz Mottiwala(Chief Commercial Officer)inDianne Whitfield(Chief Human Resources Officer)in
Co-investorsAPERTURE Venture PartnersFrazier Life SciencesVisionary VenturesVivo CapitalBain Capital Life SciencesRTW Investments L.P.+1 more
BiotechIrvine, US
Alan Waterhouse(President and Chief Operating Officer)Jason Tester(Chief Financial Officer and Secretary)James V. Mazzo(President, Chief Executive Officer and Chairman of the Board)
BoardArjun Arora(Director)Richard L. Lindstrom, M.D.(Director)William J. Link(Director)
Co-investorsEvidity Health CapitalHEALTHCARE ROYALTY PARTNERSSV Life SciencesVersant Venture AIV HoldingsVersant Ventures
Aurion Biotech develops regenerative cell therapies for ophthalmology, focused on treating blindness and vision loss from corneal endothelial disease.
BiotechHealthtechMedical DevicesSeattle, US
DAVID ROSTOV(Executive Officer)inGREG KUNST(Executive Officer, Director)PATRICK LALLY(Director)JEANNETTE BANKES(Director)CHRISTINE MCCAULEY(Director)ARNAUD LACOSTE(Executive Officer)
Co-investorsVisionary VenturesDeerfield Management Company
HealthtechSioux Falls, US
TYLER STOWATER(Director)JOHN BERDAHL(Executive Officer, Director)JEFFRY WEINHUFF(Director)
BoardRICHARD LINDSTROM(Director)J. ANDY CORLEY(Director)
Co-investorsVersant Venture AIV Holdings
Neurolens makes therapeutic eyeglass lenses with patented Contoured Prism technology and a measurement device that customizes prescriptions to reduce symptoms of eye misalignment such as headaches, neck pain, motion sickness, and eye strain.
HealthtechMedical Devices
Co-investorsTrinity Capital
A healthcare company that develops and supplies medicines, including new and more affordable therapies, aiming for reliable supply of needed treatments.
BiotechHealthtechSan Francisco, US
Jeffrey Nau(Executive Officer, Director)inMark A. Murray(Executive Officer, Director)D. Michael Ackermann(Director)
BoardWilliam J Link(Director)Ali Behbahani(Director)in
Co-investorsNew Enterprise Associates (NEA)Versant Venture AIV HoldingsVersant VenturesVida Ventures
BiotechCopley, US
Kevin Hershfield(Executive Officer, Director)
BoardWilliam Link(Director)Jeffry Weinhuff(Director)Tyler Stowater(Director)Richard Heinick(Director)Steve Pazol(Director)
Co-investorsVisionary VenturesVersant Venture AIV HoldingsVisionary Venture
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CorneagenSurface Pharmaceuticals, Inc.
Exits · 2
IPOs and acquisitions across the tracked portfolioRxsightNASDAQ: RXSTTarsus PharmaceuticalsNASDAQ: TARS
Portfolio news
latest coverage across their companiesTarsus Pharmaceuticals · americanbankingnews.com · Aug 28, 2026
Aurion Biotech · regmednet.com · Aug 20, 2026
Rxsight · tipranks.com · Aug 12, 2026
Frequently asked questions
- How many investments has Flying L Partners made?
- Flying L Partners has 9 tracked investments.
- What stage does Flying L Partners invest at?
- Flying L Partners invests at the Late Stage stage.
- What sectors does Flying L Partners focus on?
- Flying L Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Who does Flying L Partners co-invest with?
- Flying L Partners most often shares deals with Visionary Ventures, Foresite Capital, Longitude Capital, among 11 tracked co-investors.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.